|
Week (W)
|
Hyalgan® (n = 100) VAS (mm)
|
Placebo (n = 98) VAS (mm)
|
p value
|
|---|
|
Baseline (W0)
|
47.85 ± 10.76
|
45.15 ± 9.75
|
0.066
|
|
W25
|
17.00 ± 14.32
|
21.53 ± 15.69
|
0.035*
|
|
Change from W0 to W1
|
9.9 ± 12.33
|
7.55 ± 8.95
|
0.127
|
|
Change from W0 to W5
|
24.75 ± 12.66
|
20.41 ± 15.38
|
0.026
|
|
Change from W0 to W13
|
27.27 ± 14.97
|
24.01 ± 16.95
|
0.076
|
|
Change from W0 to W25 (Primary Outcome)
|
30.85 ± 14.16
|
23.62 ± 16.38
|
0.002**
|
- VAS pain scales were shows as mean ± SD.
- *P < 0.05, **P < 0.01, indicated significantly different between treatment groups.
